Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Jan 16;14(2):266-75.
doi: 10.1002/j.1460-2075.1995.tb07000.x.

Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors

Affiliations

Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors

T Kinoshita et al. EMBO J. .

Abstract

Interleukin 3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) exert their biological functions through acting on a specific receptor which consists of a ligand-specific alpha subunit and the shared common beta subunit. Inhibition by genistein of a subset of IL-3/GM-CSF-mediated signals, including c-myc induction, resulted in the abrogation of DNA synthesis, however, IL-3 still protected cells from apoptotic cell death. Conversely, a C-terminal truncated form of the GM-CSF receptor, which is missing a critical cytoplasmic region required for activation of the Ras/Raf-1/MAP kinase pathway, induced DNA synthesis, but failed to prevent cell death in response to GM-CSF. Consequently, cells died by apoptosis in the presence of GM-CSF, despite displaying a transient mitogenic response. However, expression of activated Ras protein complemented defective signalling through the mutant receptor and supported long-term proliferation in concert with GM-CSF. These results indicate that IL-3 and GM-CSF prevent apoptosis of hematopoietic cells by activating a signalling pathway distinct from the induction of DNA synthesis and that long-term cell proliferation requires the activation of both pathways.

PubMed Disclaimer

References

    1. Nature. 1985 Dec 19-1986 Jan 1;318(6047):667-70 - PubMed
    1. Mol Cell Biol. 1994 Jul;14(7):4335-41 - PubMed
    1. Anal Biochem. 1987 Apr;162(1):156-9 - PubMed
    1. Nature. 1988 Sep 29;335(6189):440-2 - PubMed
    1. Immunol Today. 1989 Feb;10(2):57-61 - PubMed

Publication types

MeSH terms